Aprio Wealth Management LLC Invests $417,000 in Waters Corporation $WAT

Aprio Wealth Management LLC purchased a new position in shares of Waters Corporation (NYSE:WAT) in the 1st quarter, Holdings Channel reports. The institutional investor purchased 1,131 shares of the medical instruments supplier’s stock, valued at approximately $417,000.

Several other institutional investors have also recently added to or reduced their stakes in WAT. Brighton Jones LLC raised its stake in Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after purchasing an additional 673 shares during the last quarter. AQR Capital Management LLC raised its stake in Waters by 35.7% in the 4th quarter. AQR Capital Management LLC now owns 23,874 shares of the medical instruments supplier’s stock valued at $8,857,000 after purchasing an additional 6,281 shares during the last quarter. Aptus Capital Advisors LLC acquired a new position in Waters in the 4th quarter valued at about $503,000. BNP Paribas Financial Markets raised its stake in Waters by 45.5% in the 4th quarter. BNP Paribas Financial Markets now owns 109,314 shares of the medical instruments supplier’s stock valued at $40,553,000 after purchasing an additional 34,209 shares during the last quarter. Finally, Benjamin Edwards Inc. raised its stake in Waters by 4.8% in the 4th quarter. Benjamin Edwards Inc. now owns 744 shares of the medical instruments supplier’s stock valued at $276,000 after purchasing an additional 34 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Trading Down 2.3%

NYSE WAT opened at $289.79 on Thursday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The company has a 50-day moving average of $306.82 and a 200-day moving average of $337.05. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The company has a market cap of $17.25 billion, a P/E ratio of 26.13, a P/E/G ratio of 2.81 and a beta of 1.07.

Waters (NYSE:WAT) last posted its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. During the same quarter in the prior year, the company posted $2.63 EPS. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, equities analysts predict that Waters Corporation will post 12.86 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on shares of Waters and gave the company a “hold” rating in a research note on Tuesday, August 5th. Wells Fargo & Company cut their target price on shares of Waters from $330.00 to $315.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 5th. Robert W. Baird lowered their price target on Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a report on Wednesday, July 16th. Finally, Jefferies Financial Group set a $385.00 price objective on shares of Waters and gave the company a “buy” rating in a research note on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Waters has an average rating of “Hold” and an average price target of $378.73.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.